Cargando…

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease

AIM: To assess the toxicity, tolerance, steroid-sparing capacity, effectiveness, and response rate to imatinib and dasatinib for the treatment of severe sclerotic chronic graft-vs-host disease (scGVHD). METHODS: This retrospective study analyzed 8 consecutive patients with severe refractory scGVHD w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Ortega, Isabel, Parody, Rocío, Servitje, Octavio, Muniesa, Cristina, Arnan, Montserrat, Patińo, Beatriz, Sureda, Anna, Duarte, Rafael F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2016
Materias:	Graft-VS-Host Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937227/ https://www.ncbi.nlm.nih.gov/pubmed/27374826 http://dx.doi.org/10.3325/cmj.2016.57.247

Ejemplares similares

Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters
por: Vukić, Tamara, et al.
Publicado: (2016)

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
por: Duraković, Nadira, et al.
Publicado: (2016)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
por: Čeović, Romana, et al.
Publicado: (2016)

Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease
por: Katić, Mašenjka, et al.
Publicado: (2016)

Corneal grafting: what eye care workers need to know
por: Yorston, David, et al.
Publicado: (2009)

Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation
por: Jeng, Kuo-Shyang, et al.
Publicado: (2018)

Saphenous vein graft aneurysm formation in a patient with idiopathic multiple aneurysms
por: Lun, Yu, et al.
Publicado: (2018)

Small caliber heparin loaded ultrafine microfiber woven graft achieved high patency rate in a preliminary study of canine carotid artery implantation
por: Fujita, Masaki, et al.
Publicado: (2020)

Biventricular Thrombi in Substance-Induced Dilated Cardiomyopathy
por: Jacobson, Andrew M., et al.
Publicado: (2020)

Persistent Left Ventricular Wall Thickening after Transcatheter Aortic Valve Replacement: A Hidden Cardiomyopathy
por: Fukui, Tomoki, et al.
Publicado: (2020)

A Rare Case of Sarcoidosis-Induced Polyserositis and Steroid-Induced Mediastinal Lipomatosis Masquerading as an Epicardial Tumor
por: Qiu, Jessica K., et al.
Publicado: (2020)

Atypical Case of Epicardial Amyloid Mass without Classical Features of Myocardial Infiltration
por: Iyer, Arun M., et al.
Publicado: (2020)

Pseudo-Paradoxical Jet Flow in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy
por: Misumi, Ikuo, et al.
Publicado: (2020)

Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib
por: Kumar, Rajiv, et al.
Publicado: (2017)

Basic Science Symposium I: Bone Graft Substitutes
por: Boyce, Todd, et al.
Publicado: (2008)

Theories and Practice
Publicado: (1920)

Hybrid endovascular exclusion of a bleeding innominate artery pseudoaneurysm in a patient with no open surgical options
por: Choudhry, Asad J., et al.
Publicado: (2019)

Recurrent pseudoaneurysm after carotid endarterectomy
por: Azouz, Vitali, et al.
Publicado: (2019)

Surgical repair of graft aneurysm following ascending-to-abdominal aortic bypass
por: Li, Jin-Dong, et al.
Publicado: (2019)

Primary selection of a pedicled rectus femoris flap for protection of aortic graft
por: Patete, Carissa L., et al.
Publicado: (2019)

Negative pressure wound therapy with intermittent instillation of rifampin for the treatment of an infected vascular bypass graft
por: Lakhiani, Chrisovalantis, et al.
Publicado: (2019)

Dasatinib/imatinib: Treatment failure: case report
Publicado: (2022)

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Ramchandren, Radhakrishnan, et al.
Publicado: (2009)

Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice
por: Santoleri, Fiorenzo, et al.
Publicado: (2013)

Sclerotic Acid
Publicado: (1878)

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
por: Chuah, Charles, et al.
Publicado: (2009)

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
por: Wei, Guoqing, et al.
Publicado: (2010)

Correction of Short Nose Deformity Using a Septal Extension Graft Combined with a Derotation Graft
por: Paik, Moo Hyun, et al.
Publicado: (2014)

Obtaining Maximal Stability with a Septal Extension Technique in East Asian Rhinoplasty
por: Jeong, Jae Yong
Publicado: (2014)

An Introduction to the Septal Extension Graft
por: Kim, Myung-Hoon, et al.
Publicado: (2014)

Effective Septal Extension Graft for Asian Rhinoplasty
por: Kim, Jae Hoon, et al.
Publicado: (2014)

Severe infolding of fenestrated-branched endovascular stent graft
por: Mirza, Aleem K., et al.
Publicado: (2018)

Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis
por: Kuroki, Marcos Takuya, et al.
Publicado: (2018)

Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis
por: Allan, David, et al.
Publicado: (2021)

Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic
por: Buk, Deborah, et al.
Publicado: (2021)

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
por: Cortes, Jorge E., et al.
Publicado: (2020)

OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection
por: Manam, Srikanth, et al.
Publicado: (2013)

Type I IFN Induces IL-10 Production in an IL-27–Independent Manner and Blocks Responsiveness to IFN-γ for Production of IL-12 and Bacterial Killing in Mycobacterium tuberculosis–Infected Macrophages
por: McNab, Finlay W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_anflf06ivurig0fg61frvuu393